Stock Market & Financial Investment News

News Breaks January 25, 2013 06:33 EDT IMGN ImmunoGen says T-DM1 marketing application under review in U.S, Europe ImmunoGen expects to reports clinical findings for three compounds and expects to advance its fourth compound, IMGN289, into clinical testing. News For IMGN From The Last 14 Days Check below for free stories on IMGN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. There are no results for IMGN Sign up for a free trial to see the rest of the stories you've been missing.